IGFBPL1 | Insulin-like growth factor binding protein-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL1 | IGF-like family member 1 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL2 | IGF-like family member 2 | Predicted secreted proteins
| | | | | Group enriched |
IGFL3 | IGF-like family member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL4 | IGF-like family member 4 | | | | | | Group enriched |
INSM1 | Insulinoma-associated 1 | Transcription factors
| | | | | Tissue enhanced |
PDK4 | Pyruvate dehydrogenase kinase, isozyme 4 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PTRF | Polymerase I and transcript release factor | Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
RAB10 | RAB10, member RAS oncogene family | | | | | | Expressed in all |
RAB13 | RAB13, member RAS oncogene family | | | | | | Expressed in all |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOCS1 | Suppressor of cytokine signaling 1 | Cancer-related genes
| | | | | Mixed |
YWHAG | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma | Plasma proteins
| | | | | Expressed in all |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADM | Adrenomedullin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGRP | Agouti related protein homolog (mouse) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANKRD26 | Ankyrin repeat domain 26 | | | | | | Expressed in all |
ANKRD62 | Ankyrin repeat domain 62 | | | | | | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | | | | | | Expressed in all |
APLN | Apelin | Predicted secreted proteins
| | | | | Tissue enhanced |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | | | | | | Group enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0A2 | ATPase, H+ transporting, lysosomal V0 subunit a2 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V0B | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0C | ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0D1 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | Plasma proteins Transporters
| | | | | Expressed in all |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | | | | | | Tissue enriched |
ATP6V0E1 | ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0E2 | ATPase, H+ transporting V0 subunit e2 | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes
| | | | | Tissue enhanced |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Transporters
| | | | | Expressed in all |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 | Transporters
| | | | | Expressed in all |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 | Transporters
| | | | | Group enriched |